Health Catalyst, Inc. HCAT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -26.26% | -12.68% | -10.90% | -6.19% | -0.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -26.26% | -12.68% | -10.90% | -6.19% | -0.04% |
| Cost of Revenue | -14.11% | -16.99% | -15.87% | -21.13% | -11.23% |
| Gross Profit | -37.92% | -7.94% | -5.44% | 12.98% | 13.72% |
| SG&A Expenses | -21.66% | -39.09% | -19.47% | -13.17% | 2.78% |
| Depreciation & Amortization | -22.88% | -13.44% | -1.66% | 25.48% | 26.35% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.47% | -23.88% | -16.66% | -16.05% | -5.17% |
| Operating Income | -70.21% | 77.61% | 50.32% | 75.67% | 37.27% |
| Income Before Tax | 280.74% | 1.65% | -370.15% | -352.14% | -45.96% |
| Income Tax Expenses | -1,058.54% | 288.89% | 92.56% | -39.36% | 108.63% |
| Earnings from Continuing Operations | 282.18% | 1.08% | -367.64% | -340.31% | -50.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 282.18% | 1.08% | -367.64% | -340.31% | -50.95% |
| EBIT | -70.21% | 77.61% | 50.32% | 75.67% | 37.27% |
| EBITDA | -463.32% | 156.11% | 144.85% | 216.26% | 137.33% |
| EPS Basic | 270.05% | 6.86% | -341.64% | -286.87% | -29.68% |
| Normalized Basic EPS | -2.74% | 65.71% | 39.31% | 56.57% | 22.78% |
| EPS Diluted | 265.63% | 6.86% | -341.64% | -286.87% | -31.36% |
| Normalized Diluted EPS | -2.01% | 65.71% | 39.31% | 56.57% | 22.78% |
| Average Basic Shares Outstanding | 7.12% | 6.23% | 5.89% | 13.82% | 16.44% |
| Average Diluted Shares Outstanding | 7.89% | 6.23% | 5.89% | 13.82% | 16.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |